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This article presents data related to the research article “Systematic
optimization of an engineered hydrogel allows for selective control of
human neural stem cell survival and differentiation after transplan-
tation in the stroke brain” (P. Moshayedi, L.R. Nih, I.L. Llorente, A.R.
Berg, J. Cinkornpumin, W.E. Lowry et al., 2016) [1] and focuses on the
biocompatibility aspects of the hydrogel, including its stiffness and
the inﬂammatory response of the transplanted organ. We have
developed an injectable hyaluronic acid (HA)-based hydrogel for
stem cell culture and transplantation, to promote brain tissue repair
after stroke. This 3D biomaterial was engineered to bind bioactive
signals such as adhesive motifs, as well as releasing growth factors
while supporting cell growth and tissue inﬁltration. We used a
Design of Experiment approach to create a complex matrix envir-
onment in vitro by keeping the hydrogel platform and cell type
constant across conditions while systematically varying peptide
motifs and growth factors. The optimized HA hydrogel promoted
survival of encapsulated human induced pluripotent stem cell
derived-neural progenitor cells (iPS-NPCs) after transplantation into
the stroke cavity and differentially tuned transplanted cell fateis an open access article under the CC BY license
ael@mednet.ucla.edu (S.T. Carmichael).
rk.
L.R. Nih et al. / Data in Brief 10 (2017) 202–209 203NPC
Astrocytic scar
Heparin
RGD
YIGSR
IKVAV
BDNF
BMP-4
Brain derived-neurotrophic factor
Bone-morphogenic protein-4S
M
T
H
D
E
E
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states. The highlights of this article include: (1) Data of cell and
bioactive signals addition on the hydrogel mechanical properties and
growth factor diffusion, (2) the use of a design of Experiment (DOE)
approach (M.W. 2 Weible and T. Chan-Ling, 2007) [2] to select multi-
factorial experimental conditions, and (3) Inﬂammatory response and
cell survival after transplantation.
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Value of the data
 This work brings a deeper understanding on the inﬂuence of cell encapsulation and bioactive
signal addition on the mechanical properties of the transplanted hydrogel and its growth factor
diffusion.
 The data in this article show how a design of experiment (DOE) approach can be used to
selectively choose multiple conditions in a multi-factorial experimental system.
 The in vivo data in this article highlight the inﬂuence of the different combinations of hydrogels
on the brain inﬂammatory response and survival of encapsulated neural progenitor cells.1. Data
A hyaluronic acid hydrogel crosslinked in situ via thiol/acrylate Michael type addition, was used for
human induced pluripotent neural precursor (iPS-NPC) 3D culture in vitro, and for a direct brain
transplantation in vivo, within the site of ischemic damage as previously described [3]. Fig. 1 shows data
related to the inﬂuence of heparin addition on mechanical properties, on cell toxicity and cell survival
in vitro, while Fig. 2 presents dataset related to the in vivo transplantation of the cell and heparin-
encapsulated hydrogel in stroked mice brain.
The gel was loaded with RGD and heparin both chemically modiﬁed to contain thiol groups and bind
the HA backbone (Fig. 1A). In order to match the mechanical properties of brain cortex, the thiol/
acrylate ratio as well as the HA weight % were modiﬁed to obtain a storage modulus of 350–400 Pa [4].
In this article, the inﬂuence of heparin addition on gel stiffness was evaluated on increasing
concentrations of heparin, showing a signiﬁcant increase of the storage modulus at a concentration of
0.3 mg/mL while higher concentrations of heparin were associated with a decreased storage modulus
(Fig. 1B). Similarly, the inﬂuence of adhesion motifs on gel stiffness was evaluated on gels containing
or not 0.3 mg/mL of heparin. The data show no signiﬁcant difference between groups. Heparin
addition on growth factor diffusion was then evaluated on HA hydrogels containing RGD and one of
the neural growth factor brain derived-neurotrophic factor (BDNF) or bone-morphogenic protein-4
(BMP-4), showing a slower diffusion with the addition of heparin (Fig. 1C).
Fig. 1. Mechanical and composition gel optimization in vitro. (A) Schematic illustration of the injectable hyaluronic acid (HA)
composed of acrylated hyaluronic acid, MMP degradable or non-degradable motifs, adhesion peptides and heparin bound
growth factors. (B) Rheology data evaluating the inﬂuence of heparin and adhesion motifs addition on HA gel stiffness.
(C) Growth factor diffusion over time, after encapsulation in an HA-RGD gel. (D) DOE heat map showing the zones of cell
survival on encapsulated iPS-NPCs in HA gel with the addition of soluble or heparin-bound BDNF and BMP-4 at day 7.
(E) Heparin toxicity assay on 2D cell culture exposed to increasing concentrations of modiﬁed or non-modiﬁed heparin. (F) DOE
data table showing the combination of heparin and growth factor leading to the most positive cell survival data in 3D at day 7.
(G) Rheology data evaluating the inﬂuence of cell addition on gel stiffness. * indicates Po0.05.
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in vitro, Induced pluripotent stem cell-derived (iPS)-NPCs were encapsulated in HA-RGD-heparin gels and
exposed to combinations of BDNF and BMP-4 concentrations rigorously selected using a statistical Design
of Experiment (DOE) approach [5]. A heat map was obtained for both heparin and non-heparin conditions,
showing that the greatest cell survival is obtained with high concentrations of BDNF and low con-
centrations of BMP-4, or low concentrations of both growth factors in the presence of heparin (Fig. 1D).
The inﬂuence of heparin addition alone, both modiﬁed and un-modiﬁed, on cell survival was then
evaluated by exposing 2D cells to increasing concentrations of heparin. No signiﬁcant difference was
observed at a concentration of 0.3 mg/mL (Fig. 1E), while the combination of heparin and BMP-4
showed the greatest iPS-NPCs survival compared to any other combination (Fig. 1F). Finally, the
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was observed with and without cells (Fig. 1G).
The same statistical approach was used to optimize adhesion peptides derived from laminin
(IKVAV and YIGSR) and ﬁbronectin (RGD) to promote in vitro survival of iPS-NPCs and demonstrated
that the optimal condition promoted neuronal differentiation [3]. A ﬁnal stage of optimization con-
sisted of combining both optimal formulations for growth factors and peptides [5] described as HA
Max for the combination leading to the greatest survival, and HA Min for the minimal cell survivalFig. 2. Biocompatibility data in vivo. (A) Schematic illustration of a brain coronal section after a cortical stroke and the
transplanted hydrogel conditions. (B) Evaluation of the astrocytic scar density, (C) the microglial response and (D) the number
of transplanted cells positive for the marker DCX, expressed in neuronal progenitors, 2 weeks after transplantation.
(E) Evaluation of Sox2 expression, a stem cell marker, in transplanted cells, (F) quantiﬁcation of vessel density in the stroke area
and (G) Cell survival after gel transplantation at 6 weeks after stroke. * and ** indicate Po0.05 and Po0.01 respectively.
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following controls: (1) No gel, [2] an HA crosslinked with an MMP-insensitive crosslinker (HA), and
(3) a non-optimized HA gel crosslinked with an MMP-sensitive crosslinker and equimolar con-
centrations of RGD, IKVAV and YIGSR (HA Nopt) (Fig. 2A). The ﬁve gel conditions were injected
directly into the stroke cavity of mice brain. Brains were harvested and processed for sectioning and
immunoﬂuorescent staining 2 weeks later.
The staining for the astrocytic scar (GFAP) and microglia (Iba-1) 2 weeks after stroke showed no
signiﬁcant difference between conditions regarding the inﬂammatory response of the brain after gel
injection (Fig. 2B, C). Similarly, no signiﬁcant difference was observed with the number of IPS-NPCs
positive for the marker Dcx at this time point (Fig. 2D).
The stem/progenitor cell expression pattern at 6 weeks after stroke was evaluated by the number
of Sox2 positive human cells in the stroke area and showed a signiﬁcantly reduced number in the HA
Min condition compared with the HA group (Fig. 2E). A quantiﬁcation of vessel density in the stroke
area showed no signiﬁcant difference between conditions (Fig. 2F).
Finally, the effect of the different gel combinations on cell survival after transplantation was
assessed by evaluating the total number of human cell present per animal and a signiﬁcantly reduced
number of cells was observed in the HA Min condition compared with the HA group (Fig. 2G).2. Experimental design, materials and methods
2.1. Cell culture
Induced pluripotent stem cells (iPS) were obtained from human ﬁbroblasts [6] and directly dif-
ferentiated in 2D culture from iPS through formation of neural rosettes [7]. On the day of trans-
plantation, human iPS-NPCs were harvested by a 5 min incubation in presence of TrypLE (Life
Technologies), centrifuged at 300 g for 5 min, re-suspended in animal origin-free culture medium and
kept on ice before injection.
2.2. Hyaluronic acid modiﬁcation
Hyaluronic acid (HA- 60,000 Da, Genzyme, Cambridge, MA) was modiﬁed as previously described
[1]. Brieﬂy, HA was functionalized with an acrylate group using a two-step synthesis as previously
described [8]. HA (2.0 g, 5.28 mmol) was dissolved in water and reacted with adipic dihydrazide
(ADH, 18.0 g, 105.5 mmol) in the presence of 1-ethyl-3-(dimethylaminopropyl) carbodiimide hydro-
chloride (EDC, 4.0 g, 20 mmol) for 8 h at a pH of 4.75. The hydrazide-modiﬁed HA (HA-ADH) was then
puriﬁed in presence of decreasing amounts of NaCl (100, 75, 50 and 25 mmol) for 4 h each via dialysis
(8000 MWCO). A puriﬁcation in deionized water for 48 h and a lyophilization followed. A resus-
pension of HA-ADH in 4-(2-hydroxyethyl)-1-piperazine ethane-sulfonic acid (HEPES) buffer (10 mM
HEPES, 150 mM NaCl, 10 mM EDTA, pH 7.4) and a reaction with N-acryloxysuccinimide (NHS-AC),
1.33 g, 4.4 mmol) was performed overnight, before puriﬁcation as described earlier, and lyophiliza-
tion. A ﬁnal product, acryl hydrazide hyaluronic acid (HA-AC) was obtained.
The degree of acrylation (14.9%) of the ﬁnal product was determined usong 1H NMR and by
dividing the multiplet peak at δ¼6.2 (cis and trans acrylate hydrogens) by the singlet peak at δ¼1.6
(singlet peak of acetyl methyl protons in HA). The speciﬁc selection of HA as a hydrogel relies on its
biocompatibility with human tissue, as it is constituted of naturally occurring brain extracellular
matrix constituents. Furthermore, HA has been shown to enhance vessel growth in wound sites and
to promote repair [5,9]. The ﬁnal puriﬁed product was lyophilized and stored at 4 °C until used.
2.3. Heparin modiﬁcation
Heparin Carboxylic acid groups (Alfa Caesar, Ward Hill, MA) were functionalized with thiol groups
by reacting heparin to EDC, NHS, and cysteamine while maintaining the pH at 4.75. The reduction of
oxidized disulﬁde groups was performed by the addition of 1,4-Dithiothreitol to the ﬁnal product
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lyophilization. An Ellman's reaction at 412 nm was used to determine the amount of thiol group
bound to heparin.
2.4. Gelation
HA-AC was mixed with HEPES buffer for 15 min at 37 °C for a complete dissolution. The appropriate
concentration of Ac-GCGYGRGDSPG-NH2 adhesion peptide (RGD, Genscript, Piscataway, NJ), Ac-
GCGYGYIGSR-NH2 (YIGSR, Genscript), Ac-IKVAVGYGCG-NH2 (IKVAV, Genscript) was dissolved in HEPES
and added to the dissolved HA-AC and allowed to react for 20 min. A total concentration of (3000 iPS-
NPCs/mL was used a ﬁnal concentration for in vitro experiments, Heparin and growth factors were then
added to the gel precursor solution, before the addition of a MMP-degradable peptide cross-linker (Ac-
GCRDGPQGIWGQDRCG-NH2, Genscript), dissolved in 0.3 M HEPES. A total of 5 mL of this solution was
pipetted onto, and sandwiched between two Sigmacote (Sigma-Aldrich) functionalized glass coverslips
and placed in an incubator for 30 min at 37 °C to gel. For in vivo experiments, the precursor was loaded
into the Hamilton syringe directly after mixing in the desired cross-linking peptide.
2.5. Rheometry
Gels were placed in a plate-to-plate rheometer (Physica MCR 301, Anton Paar, Ashland, VA) with a
frequency range of 0.1–10 rad/s under a constant strain of 1% at 37 °C.
2.6. Growth factor diffusion
Gels with or without heparin were loaded with BDNF or BMP-4 (1 mg/mL) and incubated in PBS.
The solution was collected every hour then every day and the concentration of growth factor was
measured by ELISA (R&D systems, Minneapolis, MN).
2.7. Cell survival in vitro
IPS-NPC survival at 1 and 7 days after gel gelation was measured using the CyQUANT kit (Invitrogen).
Gels were quickly degraded using in TrypLE (Invitrogen) at 37 °C and centrifuged at 250 g for 5 min. Cells
were re-suspended in 200 mL of the CyQUANT solution and the ﬂuorescence was read at 480 nm.
2.8. Design of experiments
A surface response methodology [10] was used to create a range of factor of interest using a central
composite inscribed design (CCI). For each iteration, a response surface methodology experiment was
developed in which each variable factor was given a deﬁned range (mM) to be modulated within. Here,
the Central composite on face, a speciﬁc RSM statistical design was chosen, as this system enabled us to
test the end points of each factor. Data from the cell survival assay for each condition recommended
was inputted back into the software. The data was analyzed via a least squares regression model to
determine signiﬁcance of the factors and plot the predicted response surface. Each condition was done
in triplicate and data from gels at day 7 were normalized to gels from the same condition at day 1 to
account for any differences in the numbers of cells encapsulated in the gel precursor solution.
2.9. Inducing stroke and transplantation
The procedures involving animals and human cells were performed in accordance with National
Institutes of Health Animal Protection Guidelines and approved by the UCLA Chancellor's Animal
Research Committee as well as the UCLA Ofﬁce of Environment Health and Safety. A cortical model of
photothrombotic stroke [11] was produced in 8-weeks male C57BL/6 mice (Jackson Laboratory, Bar
Harbor, ME) or Nod-Scid-gamma (NSG) mice (Jackson Laboratories). Stroke was produced under 2%
isoﬂurane in N2O:O2 (2:1) as previously described [1].
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a concentration of 50,000 cells/mL, gel (2 mL) or both were injected into compartmentalized wound using
a 25 mL Hamilton syringe (Hamilton Company, Reno, NV) and a 30 G Hamilton needle into a point 0.6 mm
below the surface of the brain at 0.3 mL/mL rate. The cell survival data in C57BL/6 mice were performed on
immunosuppressed animals with Tacrolimus (Cell Signaling, Danvers, MA). Four intraperitoneal injections
of Tacrolimus (3 mg/kg; dissolved in DMSO) were delivered for total of 4 days starting 2 days before
implanting minipumps. At the time of the stroke surgery, 3 mg/kg/day Tacrolimus (dissolved in 50%
DMSO, 15% ethanol and 35% distilled water) was infused from a minipump (Model 1002; DURECT Cor-
poration, Cupertino, CA). Minipumps were implanted subdermally between the scapulae and changed
every twoweeks. Uponminipump extraction a successful infusion of Tacrolimus was ensured by checking
for any remaining Tacrolimus solution. Additional subcutaneous injections of tacrolimus were adminis-
tered on the day of pump replacement since it takes 12 h for miniosmotic pump to start infusion.2.10. Tissue processing
The infarct size and remaining hydrogel volume was determined 4 days after stroke using 2%
triphenyl tetrazolium chloride (TTC; gr/mL, made in PBS; Sigma-Aldrich, St Louis, MO) solution on
brain sections of 1 mm thick as previously described [1]. For immunohistochemical data (Fig. 2),
16 mm thick paraformaldehyde-ﬁxed brain sections were stained at 2 and 6 weeks after stroke using
primary antibodies (Supplemental data Table S1) in blocking buffer overnight at þ4 °C followed by
ﬂuorophore-conjugated secondary antibodies in PBS for 1 h at room temperature.2.11. Tissue analysis
Stained slides were scanned using confocal microscopy (C2 Series, Nikon Instruments Inc., Mel-
ville, NY) and positively labeled signal measured by ImageJ (ImageJ v1.43, Bethesda, Maryland, USA)
and IMARIS (Bitplane, South Windsor, CT) softwares.2.12. Statistics
A Power analysis tool (Statistical Solutions LLC, Cottage Grove, WI) was used to determine the
animal sample size with the expected variance based on preliminary data. Data for each group at each
time point comprise 4–7 animals. Data is presented as mean7SEM. Multiple comparisons ANOVA
1 way with Bonferonni or Dunnet post-hoc tests were performed. When data did not ﬁt into a normal
distribution, tests appropriate for non-parametric variables, such as Mann–Whitney or Kruskal–
Wallis test and Dunn post-hoc test were employed.Acknowledgments
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